Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
International Ophthalmology
Erschienen in: International Ophthalmology 1/2019

19.12.2017 | Original Paper

Baseline demographics, clinical features, and treatment protocols of 240 patients with optic neuropathy: experiences from a neuro-ophthalmological clinic in the Aegean region of Turkey

verfasst von: Omer Karti, Dilek Top Karti, İlay Hilal Kilic, Figen Gokcay, Nese Celebisoy

Erschienen in: International Ophthalmology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To analyze the demographic patterns, clinical characteristics, and treatment protocols of optic neuropathies.

Materials and methods

The hospital data of patients with optic neuropathy admitted to the Department of Neuro-ophthalmology in a tertiary referral center in Turkey between January 2010 to January 2017 were retrospectively analyzed. Demographic patterns, clinical features, treatment protocols, and the natural disease courses were assessed.

Results

The total number of patients with optic neuropathy seen over this period was 240, which consist of 43 with idiopathic optic neuritis (17.9%), 40 with multiple sclerosis-related optic neuritis (16.7%), 12 with chronic relapsing inflammatory optic neuritis (5.0%), 12 with atypical optic neuritis (5.0%), 11 with neuromyelitis optica spectrum disorders-related optic neuritis (4.6%), 90 with non-arteritic ischemic optic neuropathy (37.5%), 4 with arteritic ischemic optic neuropathy (1.7%), 10 with traumatic optic neuropathy (4.1%), 6 with compressive optic neuropathy (2.5%), and 12 with mitochondrial optic neuropathy [9 with toxic optic neuropathy (3.7%) and 3 with Leber’s hereditary optic neuropathy (1.2%)]. There were 101 males (42%) and 139 females (58%). The mean age was 43.34 ± 15.86 years.

Conclusion

This study reported the demographics, clinical characteristics, and treatment protocols of optic neuropathies in a neuro-ophthalmology specialty clinic at a tertiary referral center in Turkey during the past decade. The data may be useful in assessing the global status of optic neuropathies.
Literatur
1.
Miller NR, Newman NJ, Biousse V et al (2007) Walsh & Hoyt’s Clinical Neuro-Ophthalmology: the essentials, 2nd edn. Lippincott Williams & Wilkins, Philadelphia
2.
3.
Barkhof F, Filippi M, Miller DH et al (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120:2059–2069CrossRefPubMed
4.
Polman C, Reingold S, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302CrossRefPubMedPubMedCentral
5.
Wingerchuk DM, Lennon VA, Pittock SJ et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489CrossRefPubMed
6.
Kidd D, Burtin B, Plant GT et al (2003) Chronic relapsing inflammatory optic neuropathy (CRION). Brain 126:276–284CrossRefPubMed
7.
Steinsapir KD, Goldberg RA (2011) Traumatic optic neuropathy: an evolving understanding. Am J Ophthalmol 151:928–933CrossRefPubMed
8.
Newman NJ, Dickersin K, Kaufman D, Kelman S, Scherer R (1996) Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the ischemic optic neuropathy decompression trial. Arch Ophthalmol 114:1366–1374CrossRef
9.
Swartz NG, Beck RW, Savino PJ et al (1995) Pain in anterior ischemic optic neuropathy. J Neuroophthalmol 15:9–10CrossRefPubMed
10.
Wakakura M, Minel-Higa R, Oono S et al (1999) Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Jpn J Ophthalmol 43:127–132CrossRefPubMed
11.
Hickman Simon J, Ko Michael, Frasat C et al (2007) Optic neuritis: an update typical and atypical optic neuritis. Neuro Ophthalmol 32:237–248CrossRef
12.
13.
Levin LA, Beck RW, Joseph MP et al (1999) The treatment of traumatic optic neuropathy: the international optic nerve trauma study. Ophthalmology 106:1268–1277CrossRefPubMed
14.
Shields AJ, Shields CL, Scartozzi R (2004) Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, Part 1. Ophthalmology 111:997–1008CrossRefPubMed
15.
Purvin V, Kawasaki A, Borruat F (2006) Optic neuropathy in patients using amiodarone. Arch Ophthalmol 124:696–701CrossRefPubMed
16.
Kerrison JB (2005) Latent, acute, and chronic Leber’s hereditary optic neuropathy. Ophthalmology 112:1–2CrossRefPubMed
17.
The clinical profile of optic neuritis (1991) Experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol 109:1673–1678CrossRef
18.
Pokroy R, Modi G, Saffer D (2001) Optic neuritis in urban black African Community. Eye (Lond) 15:469–473CrossRef
19.
Phillips PH, Newman NJ, Lynn MJ (1998) Optic neuritis in African Americans. Arch Neurol 55:186–192CrossRefPubMed
20.
Perkin GD, Rose FC (1979) Optic neuritis and its differential diagnosis. Oxford University Press, Oxford, p 248
21.
Hickman SJ, Toosy AT, Miszkiel KA et al (2004) Visual recovery following acute optic neuritis: a clinical, electrophysiological and magnetic resonance imaging study. J Neurol 251:996–1005CrossRefPubMed
22.
BrusaA Jones SJ, Plant GT (2001) Long–term remyelination after optic neuritis: a 2-year visual evoked potential and psychophysical serial study. Brain 124:468–479CrossRef
23.
Bee Y-S, Lin M-C, Wang C-C et al (2003) Optic neuritis: clinical analysis of 27 cases. Kaohsiung J Med Sci 19:105–112CrossRefPubMed
24.
Chuenkongkaew W, Chirapapaisan N (2003) Optic neuritis: characteristics and visual outcome. J Med Assoc Thai 86:238–243PubMed
25.
26.
Wang JC, Tow S, Aung T et al (2001) The presentation, aetiology, management and outcome of optic neuritis in an Asian population. Clin Exp Ophthalmol 29:312–315CrossRefPubMed
27.
Singh Sethi H, Menon V, Sharma P et al (2006) Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: a clinical case series. Indian J Ophthalmol 54:177–183CrossRef
28.
Hayreh SS (2000) Ischaemic optic neuropathy. Indian J Ophthalmol 48:171–194PubMed
29.
Hayreh SS, Zimmerman MB (2008) Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 246:1029–1046CrossRefPubMedPubMedCentral
30.
Tang R, Li H, Regner V et al (1986) Traumatic optic neuropathy: analysis of 37 cases. Invest Ophthalmol Vis Sci 27:102
31.
Lepore FE (1991) The origin of pain in optic neuritis. determinants of pain in 101 eyes with optic neuritis. Arch Neurol 48:748–749CrossRefPubMed
32.
Lim SA, Goh KY, Tow S et al (2008) Optic neuritis in Singapore. Singapore Med J 49:667–671PubMed
33.
Woung LC, Lin CH, Tsai CY et al (2007) Optic neuritis among national health insurance enrollees in Taiwan, 2000–2004. Neuroepidemilogy 29:250–254CrossRef
34.
Beck RW, Cleary PA, Backlund JC (1994) The course of visual recovery after optic neuritis. Experience of optic neuritis treatment trial. Ophthalmology 101:1771–1778CrossRefPubMed
35.
Rizzo JF, Lessell S (1991) Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Arch Ophthalmol 109:1668–1672CrossRefPubMed
36.
37.
The Ischemic Optic Neuropathy Decompression Trial Research Group (1995) Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 273:625–632CrossRef
38.
Arnold AC, Hepler RS (1994) Natural history of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 14:66–69CrossRefPubMed
39.
Yee RD, Selky AK, Purvin VA (1994) Outcomes of optic nerve sheath decompression for nonarteritic ischemic optic neuropathy. J Neuroophthalmol 14:70–76PubMed
40.
Sawle GV, James CB, Russell RW (1990) The natural history of non-arteritic anterior ischaemic optic neuropathy. J Neurol Neurosurg Psychiatry 53:830–833CrossRefPubMedPubMedCentral
41.
Hayreh SS, Zimmerman MB (2008) Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology 115:298–305CrossRefPubMed
42.
Hayreh SS, Zimmerman B (2003) Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica 217:239–259CrossRefPubMed
43.
Liu GT, Glaser JS, Schatz NJ et al (1994) Visual morbidity in giant cell arteritis: clinical characteristics and prognosis for vision. Ophthalmology 101:1779–1785CrossRefPubMed
44.
Kupersmith MJ, Langer R, Mitnick H et al (1999) Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy. Br J Ophthalmol 83:796–801CrossRefPubMedPubMedCentral
45.
Danesh-Meyer H, Savino PJ, Gamble GG (2005) Poor prognosis of visual outcome after visual loss from giant cell arteritis. Ophthalmology 112:1098–1103CrossRefPubMed
46.
Hayreh SS, Zimmerman B, Kardon RH (2002) Visual improvement with corticosteroid therapy in giant cell arteritis: report of a large study and review of the literature. Acta Ophthalmol Scand 80:353–367CrossRef
47.
Foroozan R, Deramo VA, Buono LM et al (2003) Recovery of visual function in patients with biopsy-proven giant cell arteritis. Ophthalmology 110:539–542CrossRefPubMed
48.
49.
Radoi C, Garcia T, Brugniart C (2014) Intravitreal triamcinolone injections in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 252:339–345CrossRefPubMed
50.
Yaman A, Selver OB, Saatci AO et al (2008) Intravitreal triamcinolone acetonide injection for acute non-arteritic anterior ischaemic optic neuropathy. Clin Exp Optom 91:561–564CrossRefPubMed
51.
Bajin MS, Selver OB, Taskin O et al (2011) Single intravitreal ranibizumab injection in eyes with acute non-arteritic anterior ischaemic optic neuropathy. Clin Exp Optom 94:367–370CrossRefPubMed
52.
Thorne JE, Jabs DA (2005) Ocular manifestations of the rheumatic diseases. In: William T (ed) Duane’s clinical ophthalmology, vol 5. Lippincott Williams & Wilkins, Philadelphia, pp 22–24
53.
Piccolo L, Woodhall M, Tackley G et al (2016) Isolated new onset atypical optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up. J Neurol 263:370–379CrossRefPubMed
54.
Petzold A, Plant GT (2014) Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol 261:17–26CrossRefPubMed
Metadaten
Titel
Baseline demographics, clinical features, and treatment protocols of 240 patients with optic neuropathy: experiences from a neuro-ophthalmological clinic in the Aegean region of Turkey
verfasst von
Omer Karti
Dilek Top Karti
İlay Hilal Kilic
Figen Gokcay
Nese Celebisoy
Publikationsdatum
19.12.2017
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 1/2019
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-017-0799-5

Weitere Artikel der Ausgabe 1/2019

International Ophthalmology 1/2019 Zur Ausgabe

Correction

Correction to: Primary vitrectomy with short-term silicone oil tamponade for uncomplicated rhegmatogenous retinal detachment

Original Paper

Comparative evaluation of the aqueous humor proteome of primary angle closure and primary open angle glaucomas and age-related cataract eyes

Photo Essay

Choroidal hypoperfusion: an indicator of low tension neovascular glaucoma

Review

Could adverse effects and complications of selective laser trabeculoplasty be decreased by low-power laser therapy?

Original Paper

Clinical characteristics and ophthalmologic findings of pituitary adenoma in Korean patients

Original Paper

Mutations in MERTK are not associated with age-related macular degeneration

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Therapieverfahren in der Augenheilkunde CME-Artikel

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Erkrankungen der Hornhaut CME-Artikel

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise